| Matthew C Hulse, MD | |
|
1215 Lee St, Charlottesville, VA 22908-0001 | |
| (434) 924-2283 | |
| (434) 982-0019 |
| Full Name | Matthew C Hulse |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 13 Years |
| Location | 1215 Lee St, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619261310 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Musc Medical Center | Charleston, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Medical Associates Of The Medical University Of South Carol | 6305758574 | 1297 |
News Archive
Students of the Medicine Degree at the CEU UCH University in Castellón, Iván Echeverria and Carlos Galera-Román, and the student of the International Doctorate School of the CEU, Alejandro Fuertes-Saiz, have presented two pieces of research at the third edition of the International Congress of Dual Disorders, which was held in Madrid on June 19-22.
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced financial results for the three and six months ended June 30, 2010.
The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood disorder called chronic immune thrombocytopenic purpura (ITP). Promacta can be used in these children when they have not achieved an appropriate response using other ITP medicines or surgery to remove the spleen.
Duke University chemists are developing ways to bind up iron in the brain to combat the neurological devastation of Parkinson's and Alzheimer's diseases.
With the world's elderly population expected to double by 2050, understanding how aging affects the body is an important focus for researchers globally. Cardiovascular disease, the No. 1 cause of death worldwide, often is associated with aging arteries that restrict blood flow. Now, University of Missouri researchers have identified an age-related cause of arterial dysfunction, a finding that could lead to future treatments for some forms of vascular disease.
› Verified 6 days ago
| Entity Name | University Medical Associates Of The Medical University Of South Carol |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043241110 PECOS PAC ID: 6305758574 Enrollment ID: O20031105000291 |
News Archive
Students of the Medicine Degree at the CEU UCH University in Castellón, Iván Echeverria and Carlos Galera-Román, and the student of the International Doctorate School of the CEU, Alejandro Fuertes-Saiz, have presented two pieces of research at the third edition of the International Congress of Dual Disorders, which was held in Madrid on June 19-22.
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced financial results for the three and six months ended June 30, 2010.
The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood disorder called chronic immune thrombocytopenic purpura (ITP). Promacta can be used in these children when they have not achieved an appropriate response using other ITP medicines or surgery to remove the spleen.
Duke University chemists are developing ways to bind up iron in the brain to combat the neurological devastation of Parkinson's and Alzheimer's diseases.
With the world's elderly population expected to double by 2050, understanding how aging affects the body is an important focus for researchers globally. Cardiovascular disease, the No. 1 cause of death worldwide, often is associated with aging arteries that restrict blood flow. Now, University of Missouri researchers have identified an age-related cause of arterial dysfunction, a finding that could lead to future treatments for some forms of vascular disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew C Hulse, MD Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Matthew C Hulse, MD 1215 Lee St, Charlottesville, VA 22908-0001 Ph: (434) 924-2283 |
News Archive
Students of the Medicine Degree at the CEU UCH University in Castellón, Iván Echeverria and Carlos Galera-Román, and the student of the International Doctorate School of the CEU, Alejandro Fuertes-Saiz, have presented two pieces of research at the third edition of the International Congress of Dual Disorders, which was held in Madrid on June 19-22.
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced financial results for the three and six months ended June 30, 2010.
The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood disorder called chronic immune thrombocytopenic purpura (ITP). Promacta can be used in these children when they have not achieved an appropriate response using other ITP medicines or surgery to remove the spleen.
Duke University chemists are developing ways to bind up iron in the brain to combat the neurological devastation of Parkinson's and Alzheimer's diseases.
With the world's elderly population expected to double by 2050, understanding how aging affects the body is an important focus for researchers globally. Cardiovascular disease, the No. 1 cause of death worldwide, often is associated with aging arteries that restrict blood flow. Now, University of Missouri researchers have identified an age-related cause of arterial dysfunction, a finding that could lead to future treatments for some forms of vascular disease.
› Verified 6 days ago
Farnaz M Gazoni, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Katherine T, Forkin, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Edward C. Nemergut, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Allison J. Bechtel, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Kristi Hackworth Rose, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2331 Seminole Ln Ste 201, Charlottesville, VA 22901 Phone: 434-293-4995 Fax: 434-971-3434 | |
Sunny S. Chiao, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Logan David Kinch, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 545 Ray C Hunt Dr Ste 316, Charlottesville, VA 22903 Phone: 434-243-5676 Fax: 434-243-5689 |